UPDATE 1-Amgen?s Repatha effective; question is for which patients?FDA

[ahlam1399]

UPDATE 1-Amgen?s Repatha effective; question is for which patients?FDA
WASHINGTON, June 8 (Reuters) - Amgen Inc's experimental drug Repatha lowered cholesterol in clinical trials and did **t cause a marked disparity in deaths or serious adverse events but showed potential safety issues that should be explored, according to a preliminary review by the U.S. Food and Drug Administration.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/470a5efa/sc/14/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=TfTqc8ZqSg0:XGkejvZb18c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=TfTqc8ZqSg0:XGkejvZb18c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=TfTqc8ZqSg0:XGkejvZb18c:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=TfTqc8ZqSg0:XGkejvZb18c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=TfTqc8ZqSg0:XGkejvZb18c:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/TfTqc8ZqSg0